Cite
HARVARD Citation
Malecek, M. et al. (n.d.). Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab. American journal of hematology. 92 (11), pp. 1156-1162. [Online].